John J. Haluschak

Combined Chemoradiotherapy Regimens of Paclitaxel and Carboplatin for Locally Advanced Non–Small-Cell Lung Cancer: A Randomized Phase II Locally Advanced Multi-Modality Protocol

Chandra P. Belani, Hak Choy, P. Bonomi et al. · Journal of Clinical Oncology · 2005 · 428 citations

Medicine, Oncology, Radiation Oncology +16

Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement

Ronald C. Chen, R. Bryan Rumble, D.A. Loblaw et al. · Journal of Clinical Oncology · 2016 · 362 citations · Full text

Medicine, Oncology, Urology +10

Clinically Localized Prostate Cancer: ASCO Clinical Practice Guideline Endorsement of an American Urological Association/American Society for Radiation Oncology/Society of Urologic Oncology Guideline

Justin E. Bekelman, R. Bryan Rumble, Ronald C. Chen et al. · Journal of Clinical Oncology · 2018 · 197 citations

Medicine, Oncology, Radiation Oncology +12

O-263 Randomized 3-arm phase II study of paclitaxel (T), carboplatin (C), and thoracic radiation (TRT) for patients with stage III non-small cell lung cancer (NSCLC). Report of locally advanced multimodality protocol (LAMP) - ACR 427

P. Bonomi, Walter J. Curran, Hak Choy et al. · Lung Cancer · 2003 · 45 citations

Medicine, Oncology, Radiation Oncology +13

Some clotting factors in plasma during danazol therapy: free and total protein S, but not C4b-binding protein, are elevated by danazol therapy.

Hilda Thorisdottir, Judith A. Evans, Howard J. Schwartz et al. · PubMed · 1992 · 10 citations

Medicine, Hematology, Pharmacology +13